All treatments
Treatment
Cytarabin Accord 100 mg/ml Injektions-/Infusionslösung clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic exploratory (Phase II)
Magrolimab plus intensive chemotherapy in newly diagnosed “ELN intermediate or poor-risk” AML patients intended to undergo allogeneic stem cell transplantation, a Phase 2, Single-arm, Open-Label Study (MAGROLIC)
This study looks at a new drug, Magrolimab, combined with standard chemotherapy for adults with newly diagnosed, higher-risk Acute Myeloid Leukemia (AML) who are planning to have a stem cell transplant. It aims to see how well this combination works in getting the disease under control.
For: High-risk Myelodysplastic neoplasia · Acute myeloid leukemiaGermany - AuthorisedTherapeutic confirmatory (Phase III)
International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 - A Randomized Phase III Study Conducted by the Resistant Disease Committee of the International BFM Study Group - IntReALL BCP 2020
This study looks at new ways to treat children with a type of blood cancer called B-cell acute lymphoblastic leukaemia, which has come back after earlier treatment. It compares different drug combinations to find the most effective and safest options for them.
For: Relapsed Acute Lymphoblastic Leukemia (ALL)Netherlands · Czechia · Italy